Controlling pharmacy costs through lower network reimbursement rates and administrative fees will produce savings but will never alone stem the tide of inflation. Manufacturers will continue to raise the price of their products. Direct to consumer advertising is more prevalent than ever, creating demand for prescription medications.
While Matrix maintains competitive network rates and administrative fees, our focus today is to use our clinical expertise and partner relationships to drive appropriate utilization and improved outcomes. Data and experience are the keys to our success. Identifying patients who will benefit the most from DM programs and effectively engaging them is where most competitors fail. Matrix leverages the database of claims to identify patients who have not found their way to the traditional disease management process. Once enrolled, these patients are counseled on the importance of compliance and evaluated for therapy adjustment.
While matrix will design a benefit that ensures patients with chronic conditions are using the most cost effective therapy and delivery system, our most intensive programs will focus on the sickest most costly patients.